These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 18230980)

  • 1. Alopecia areata universalis elicited during treatment with adalimumab.
    Pelivani N; Hassan AS; Braathen LR; Hunger RE; Yawalkar N
    Dermatology; 2008; 216(4):320-3. PubMed ID: 18230980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab).
    Chaves Y; Duarte G; Ben-Said B; Tebib J; Berard F; Nicolas JF
    Dermatology; 2008; 217(4):380. PubMed ID: 18849606
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of alopecia areata universalis in a patient receiving adalimumab.
    Garcia Bartels N; Lee HH; Worm M; Burmester GR; Sterry W; Blume-Peytavi U
    Arch Dermatol; 2006 Dec; 142(12):1654-5. PubMed ID: 17179003
    [No Abstract]   [Full Text] [Related]  

  • 4. Alopecia areata following adalimumab.
    Kirshen C; Kanigsberg N
    J Cutan Med Surg; 2009; 13(1):48-50. PubMed ID: 19298772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia areata during treatment with adalimumab: therapy with an alternative TNF-alpha inhibitor is possible.
    Zschoche C; Bidier M; Hadaschik E
    J Dtsch Dermatol Ges; 2013 May; 11(5):450-3. PubMed ID: 23279686
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alopecia areata during anti-TNF alpha therapy: Nine cases].
    Le Bidre E; Chaby G; Martin L; Perrussel M; Sassolas B; Sigal ML; Kaassis C; Lespessailles E; Nseir A; Estève E
    Ann Dermatol Venereol; 2011; 138(4):285-93. PubMed ID: 21497255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: a 'class effect' of TNF-alpha antagonists or simply an anti-psoriatic treatment adverse reaction?
    Rallis E; Korfitis C; Stavropoulou E; Papaconstantis M
    J Dermatolog Treat; 2010 Jan; 21(1):3-5. PubMed ID: 19701844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.
    Chew AL; Bennett A; Smith CH; Barker J; Kirkham B
    Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness and safety of biological therapy with adalimumab].
    Fehér J; Lengyel G
    Orv Hetil; 2009 Jun; 150(26):1215-22. PubMed ID: 19546078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata during treatment of psoriasis with adalimumab and leflunomide: a case and review of the literature.
    Navarro R; Daudén E; Gallo E; Santiago Sánchez-Mateos D; García-Diez A
    Skin Pharmacol Physiol; 2012; 25(2):107-10. PubMed ID: 22301842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia areata universalis during off-label treatment with Infliximab in a patient with Behçet disease.
    Beccastrini E; Squatrito D; Emmi G; Fabbri P; Emmi L
    Dermatol Online J; 2010 Sep; 16(9):15. PubMed ID: 20875336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles.
    Ettefagh L; Nedorost S; Mirmirani P
    Arch Dermatol; 2004 Aug; 140(8):1012. PubMed ID: 15313825
    [No Abstract]   [Full Text] [Related]  

  • 13. Biologic agents and alopecia areata.
    Katoulis AC; Alevizou A; Bozi E; Georgala S; Mistidou M; Kalogeromitros D; Stavrianeas NG
    Dermatology; 2009; 218(2):184-5. PubMed ID: 19018127
    [No Abstract]   [Full Text] [Related]  

  • 14. Adalimumab therapy of psoriasis and psoriatic arthritis in a patient with cirrhosis of the liver.
    Piel S; Dissemond J
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S117-8. PubMed ID: 19119119
    [No Abstract]   [Full Text] [Related]  

  • 15. Exacerbation of psoriatic skin lesions in a patient with psoriatic arthritis receiving adalimumab.
    Borrás-Blasco J; Gracia-Perez A; Nuñez-Cornejo C; Rosique-Robles JD; Mateu-Puchades A; Casterá MD; Rubio-Fabra M
    J Clin Pharm Ther; 2008 Jun; 33(3):321-5. PubMed ID: 18452420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody.
    Baker DE
    Rev Gastroenterol Disord; 2004; 4(4):196-210. PubMed ID: 15580154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic therapy (TNF-alpha antagonists)-induced psoriasis: a cytokine imbalance between TNF-alpha and IFN-alpha?
    Cuchacovich R; Espinoza CG; Virk Z; Espinoza LR
    J Clin Rheumatol; 2008 Dec; 14(6):353-6. PubMed ID: 19033869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.
    Deng A; Harvey V; Sina B; Strobel D; Badros A; Junkins-Hopkins JM; Samuels A; Oghilikhan M; Gaspari A
    Arch Dermatol; 2006 Feb; 142(2):198-202. PubMed ID: 16490847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis.
    Girolomoni G; Altomare G; Ayala F; Berardesca E; Calzavara-Pinton P; Chimenti S; Peserico A; Puglisi Guerra A; Vena GA
    Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):548-60. PubMed ID: 22296031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous pseudolymphoma with two types of anti-TNFα: a class effect?].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2012 Oct; 139(10):695-6. PubMed ID: 23122389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.